Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Raydium crypto surges 14% as negative funding raises short squeeze prospects

Raydium crypto surges 14% as negative funding raises short squeeze prospects

AMBCryptoAMBCrypto2026/10/08 21:33

Raydium [RAY] spent most of the summer going nowhere. Then in early September, it finally woke up.

Why does that matter today? Here’s the rundown.

Raydium crypto jumps 14% in a day!

Most of the market had a bad week, but Raydium clearly did not get the memo.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

RAY traded around $0.90 before its September breakout and climbed as high as $2.56 on 7 October, an increase of roughly 184%. Even after retreating to $2.31, the token remained more than 150% above its early-September level.

That hardly makes a difference if you think of the bigger picture. Before its breakout on September 5, RAY was around $0.90.

It has more than doubled in the past month alone.

The pace is still there, but the tiredness is obvious. RSI was at 66; back in September, it was running above 80.

Chaikin Money Flow is positive at 0.06, but well off its September highs.

But here’s where it gets interesting.

OI went from about $13 million to over $20 million during today’s rally. At the same time, funding went deep into the red, close to -0.20%.

A lot of traders opened short positions, betting the pump wouldn’t last. OI has since dropped to about $16.3 million, and funding is still negative at -0.08%.

The bears are still here, but in fewer numbers.

Why is RAY running when everything else isn’t?

Meteora handled $2.3 billion, and Orca $1.2 billion. Those two together still don’t match Raydium.

The most traded ticker? NVDAx, the tokenized version of NVIDIA. There were 115 others, but AI names were clearly what people came for.

So while most of the market sat this week out, RAY had actual trading volume behind it.

Final Summary

  • Raydium (RAY) jumped 14% in a day; more than doubled in the past month.
  • Raydium handled about $6.1 billion of Solana’s $12.4 billion tokenized stock DEX volume this year.

 

News Image 0News Image 1News Image 2News Image 3
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - RBC expects gradual improvement in North American and European building materials stocks in the third quarter

October 9 - RBC expects the performance of most European building material products to gradually improve quarter-on-quarter in Q3, but notes that geopolitical uncertainties in the US will continue to drive up cost inflation and increase market volatility. RBC anticipates that sales in Europe will remain sluggish due to heatwaves and rising mortgage rates, while a weak US housing market and the lack of a significant hurricane season will prompt roofing material companies to enter a destocking cycle. The firm is more optimistic about Germany’s Heidelberg Group (HEIG.DE), upgrading its rating to “outperform,” and points out that the company has handled the challenging quarter caused by extreme weather far better than its peers. Due to severe cost headwinds such as rising diesel and natural gas prices, RBC downgraded the ratings of US and French construction companies Knife River (KNF.N) and Saint-Gobain (SGOB.PA) from “outperform” to “market perform.” (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them solely for the ease of the reader. Reuters assumes no liability for any damages or losses that may arise from the use of automated translation functions.)

路透社•2026/10/09 07:16

3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million

Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.

智通财经•2026/10/09 07:11

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.

Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.

智通财经•2026/10/09 07:09

Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.

Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.

智通财经•2026/10/09 07:08